Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Skin Neoplasms × Mycophenolic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 19 Lymphoma, Non-Hodgkin 19 Leukemia, Myeloid, Acute 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Leukemia, Lymphocytic, Chronic, B-Cell 16 Leukemia 16 Hodgkin Disease 15 Multiple Myeloma 14 Lymphoma, Mantle-Cell 13 Lymphoma, Large B-Cell, Diffuse 13 Lymphoma 13 Lymphoma, Follicular 12 Lymphoma, B-Cell, Marginal Zone 11 Burkitt Lymphoma 10 Primary Myelofibrosis 9 Lymphoma, Large-Cell, Immunoblastic 9 Leukemia, Myelomonocytic, Chronic 9 Neoplasms, Plasma Cell 8 Leukemia, Myelomonocytic, Juvenile 8 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Congenital Abnormalities 8 Anemia, Refractory, with Excess of Blasts 8 Sezary Syndrome 7 Mycosis Fungoides 7 Blast Crisis 7 Myeloproliferative Disorders 6 Myelodysplastic-Myeloproliferative Diseases 6 Lymphoma, Large-Cell, Anaplastic 6 Leukemia, Myeloid, Chronic-Phase 6

Interventions

Cyclophosphamide 11 fludarabine 8 aldesleukin 8 fludarabine phosphate 6 pembrolizumab 5 Nivolumab 4 Ipilimumab 4 Interleukin-2 4 dabrafenib 2 Vemurafenib 2 Biopsy 2 Aminolevulinic Acid 2 varlilumab 1 trametinib 1 tilsotolimod 1 spartalizumab 1 sotigalimab 1 sonidegib 1 smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1 glembatumumab vedotin 1 eprenetapopt 1 encorafenib 1 cemiplimab 1 cabozantinib 1 binimetinib 1 bempegaldesleukin 1 abobotulinumtoxinA 1 X-Rays 1 Tranexamic Acid 1 Tacrolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00866684 2025-03-14

PROSKIN

Charite University, Berlin, Germany

Phase 4 Terminated

44 enrolled 7 charts

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡